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Abstract
Propionibacterium acnes has been implicated as an etiologic agent of sarcoidosis since the
isolation of this bacterium from sarcoid lesions. We experimentally produced a murine pulmonary
granuloma model using P. acnes with several features that simulate sarcoidosis. Mice were sensi-
tized with heat-killed P. acnes and complete Freund’s adjuvant and were subsequently challenged
with heat-killed P. acnes at 2-week intervals. P. acnes-challenged mice developed epitheloid
cell granulomas in the lungs. These mice showed a pulmonary immune response characterized
by an increased number of T-lymphocytes, especially CD4 cells, and the ratio of CD4/CD8 in
bronchoalveolar lavage (BAL) fluid also increased. Furthermore, significant elevations in both
angiotensin-converting enzyme (ACE) serum levels and antibody titers against P. acnes were ob-
served. Mice sensitized with P. acnes without complete Freund’s adjuvant were capable of forming
pulmonary granulomas, which appeared to be caused by indigenous P. acnes. The genome of P.
acnes was found in the lungs, BAL cells, hilar lymph nodes, liver, and spleen in non-sensitized
mice, which were thought to be germ-free. These results suggest that the immune response against
indigenous P. acnes may play an important role in the pathogenesis of granuloma formation in a
murine model.
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Propionibacterium acnes has been implicated as an etiologic agent of sarcoidosis since the isolation of 
this bacterium from sarcoid lesions.  We experimentally produced a murine pulmonary granuloma 
model using P. acnes with several features that simulate sarcoidosis.  Mice were sensitized with heat-
killed P. acnes and complete Freundʼs adjuvant and were subsequently challenged with heat-killed P. 
acnes at 2-week intervals.  P. acnes-challenged mice developed epitheloid cell granulomas in the lungs.  
These mice showed a pulmonary immune response characterized by an increased number of 
T-lymphocytes,  especially CD4＋ cells,  and the ratio of CD4＋/CD8＋ in bronchoalveolar lavage (BAL) 
ﬂuid also increased.  Furthermore,  signiﬁcant elevations in both angiotensin-converting enzyme (ACE) 
serum levels and antibody titers against P. acnes were observed.  Mice sensitized with P. acnes without 
complete Freundʼs adjuvant were capable of forming pulmonary granulomas,  which appeared to be 
caused by indigenous P. acnes.  The genome of P. acnes was found in the lungs,  BAL cells,  hilar 
lymph nodes,  liver,  and spleen in non-sensitized mice,  which were thought to be germ-free.  These 
results suggest that the immune response against indigenous P. acnes may play an important role in the 
pathogenesis of granuloma formation in a murine model.
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arcoidosis is a systemic disease characterized 
by the presence of noncaseating epitheloid cell 
granuloma; it commonly involves the lungs,  eyes,  
lymph nodes,  and skin.  Although the pathogenesis of 
sarcoidosis has been widely investigated,  its etiology 
remains unknown [1-3].  Noncaseating granuloma is a 
typical histological feature of sarcoidosis; several 
types of bacteria,  fungi,  chemical,  and non-immuno-
logical stimuli can induce granuloma formation.  In fact,  
the process of granuloma formation is thought to be a 
physiologic step in the delayed immune response that 
prevents the spread of noxious and infectious microor-
ganisms [4].
　 Frequent isolation of Propionibacterium acnes from 
sarcoid lymph nodes has been reported by Homma et 
al.  [5,  6].  Recently,  P. acnes was implicated as the 
etiologic agent of sarcoidosis,  based on the isolation 
of this bacterium from sarcoid lesions using bacterio-
logical,  immunohistochemical,  and molecular approaches 
[7-11].  Therefore,  we experimentally produced a 
murine pulmonary granuloma model with P. acnes that 
shares several features with those of sarcoidosis.  We 
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then investigated the immune status in response to 
sarcoidosis in experimental mice.
Materials and Methods
　 Animals. This experiment complied with the 
guidelines of the Institutional Animal Care and Use 
Committee of Okayama University.  C57BL/6J mice 
(females,  6-8 weeks of age) were kept under speciﬁc 
pathogen-free conditions at the Advanced Science 
Research Center of Okayama University.  Mice were 
divided into 4 groups (n＝10 per group).
　 Induction of granuloma. P. acnes (ATCC 
6919) were cultured on thioglycollate medium II 
(Dainippon Pharmaceutical,  Tokyo,  Japan) supple-
mented with L-cysteine in an anaerobic chamber,  and 
then were harvested,  the samples washed,  and a por-
tion of the culture was counted in a Fuchs-Rosenthal 
counting chamber.  Then,  P. acnes were heat-killed for 
30min at 65℃.  The mice were divided into 4 groups 
(n＝10 per group).  Group 1 was a control group that 
had been sensitized by subcutaneous injection of 0.2ml 
saline on day 1 into the footpad,  and on days 14 and 
28 in the dorsal region.  Group 2 was sensitized by 
subcutaneous injection of a mixture (0.2ml) of com-
plete Freundʼs adjuvant (CFA,  Cappel,  Cochranville,  
PA,  USA) and P. acnes (2µg/ml) on day 1 into the 
footpad,  and were challenged with 0.2ml of P. acnes 
suspension (2µg/ml) injected into the dorsal region on 
days 14 and 28.  Group 3 mice were sensitized by 
subcutaneous injection of a mixture (0.2ml) of CFA 
and P. acnes (2µg/ml) into the footpad on day 1,  and 
were challenged with a subcutaneous injection of P. 
acnes suspension (0.2ml of 2µg/ml) on days 14,  28,  
and 42 into the dorsal region.  Group 4 was sensitized 
by subcutaneous injection of P. acnes suspension 
(0.2ml of 2µg/ml) on days 1,  14,  and 28 into the 
dorsal region.  From groups 1,  2,  and 4,  samples 
were collected 6 weeks after sensitization; samples 
from group 3 were collected 8 weeks after sensitiza-
tion (Fig.  1).
　 Bronchoalveolar lavage (BAL) ﬂuid and 
blood. Mice were anesthetized by an intraperito-
neal injection of pentobarbital sodium,  and were then 
ﬁxed to a board.  First,  blood samples were collected 
from the abdominal space by excising the vena cava.  
Blood was centrifuged at 3,000rpm for 20min.  After 
centrifugation,  the serum was stored at －80℃.  
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Fig. 1　 Experimental protocols.  Mice were divided into 4 groups of 10 mice each.  Group 1 was the control group,  which was sensitized 
by subcutaneous (s.c.) injection of 0.2ml saline into the footpad on day 1,  and into the dorsal region on days 14 and 28.  Group 2 mice 
were sensitized by subcutaneous injection of a mixture (0.2ml) of complete Freundʼs adjuvant (CFA,  Cappel,  Cochranville,  PA,  USA) and 
P. acnes (PA) (2µg/ml) into the footpad on day 1,  and were challenged with 0.2ml of P. acnes suspension (2µg/ml),  injected into the 
dorsal region on days 14 and 28.  Group 3 mice were sensitized by subcutaneous injection of a mixture (0.2ml) of CFA and P. acnes (2µg/
ml) into the footpad on day 1,  and were challenged with subcutaneous injection of a P. acnes suspension (0.2ml of 2µg/ml) into the dor-
sal region on days 14,  28,  and 42.  Group 4 was sensitized by subcutaneous injection of P. acnes suspension (0.2ml of 2µg/ml) into the 
dorsal region on days 1,  14,  and 28.  In groups 1,  2,  and 4,  samples were collected 6 weeks after sensitization; in group 3,  samples were 
collected 8 weeks after sensitization.
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Subsequently,  the lungs were lavaged with saline (2
×1ml,  37℃) via a trachea tube.  The volume of BAL 
ﬂuid collected was measured for each sample,  and the 
number of cells was counted.  The BAL ﬂuid was 
centrifuged at 1,800rpm for 15min at 4℃.  After 
centrifugation,  the supernatant was stored at －80℃.  
The sediment was resuspended in 1ml of phosphate 
buﬀered saline (PBS) containing 1ｵ bovine serum 
albumin (BSA),  and smear preparations were pre-
pared by an automatic smear system (1,500rpm,  
5min).  The preparations were stained with Giemsa,  
and diﬀerential cell counts were performed.  The 
remaining BAL cells were analyzed in a ﬂow cytome-
ter.  The BAL cells were stained with PE-conjugated 
anti-CD3 antibody (rat; Immunotech,  Marseilles,  
France) and FITC-conjugated anti-CD4 antibody (rat;  
Immunotech) or anti-CD8 antibody (rat; Immunotech),  
and were measured using FACScan (BD,  Franklin,  
NJ,  USA).  Finally,  the lungs,  hilar lymph nodes,  
liver,  and spleen were removed and stored at －80℃,  
and the removed portions were ﬁxed in formalin.
　 Histological studies. Fixed tissues were 
paraﬃn-embedded and cut into 4-µm sections,  which 
were then stained with hematoxylin and eosin (HE) for 
histological evaluation.
　 Serum angiotensin-converting enzyme (ACE) 
measurement. The ACE activity was measured 
using ACE color (Fuji Rebio,  Tokyo,  Japan),  in 
which the colorimetric analysis of quinoneimine dye 
produced by the substrate p-hydroxybenzoil glycyl-L-
His-L-leu was carried out at 405nm.
　 Measurement of P. acnes antibody in serum.
Levels of P. acnes antibody in the serum were mea-
sured by whole bacterial enzyme-linked immunosor-
bent assay (ELISA) [12].  Each well of a 96-well 
microtiter plate (Nunc,  Roskilde,  Denmark) was 
coated with 100µl of Poly-L-lysine (Sigma,  St.  Louis,  
MO,  USA) and kept overnight at 4℃.  The plate was 
washed 3 times with washing buﬀer (0.1M PBS 
pH7.4 with 0.05ｵ Tween20,  PBST).  The P. acnes 
suspension (10µg/ml) was added to the plate (50-µl 
each well),  which was then coated with heat-killed P. 
acnes overnight at 4℃.  After having been washed,  the 
plate was blocked by 150µl PBST with BSA at room 
temperature for 30min.  After the plate had been 
washed,  serum diluted in PBST with BSA (50µl) was 
added,  and the plate was then left at room tempera-
ture for 2h.  After a subsequent wash,  the plate was 
incubated with 50µl of horseradish-peroxidase (HRP)-
conjugated anti mouse-IgG goat antibody (Sigma) at 
room temperature for 1h.  The plate was again washed,  
and enzyme substrate (ABTS; Sigma) with 0.05ｵ 
H2O2 solution was added to yield a total volume of 
100µl.  Absorbance was read at 405nm on a micro-
plate reader.
P. acnes DNA analysis by quantitative real-
time polymer chain reaction (PCR)
1. P. acnes DNA preparation. We compared the 
eﬃcacy of 2 approaches to DNA extraction,  i.e.,  the 
Achromopeptidase (WAKO,  Osaka,  Japan) and 
BACTOZOL (Molecular Research Center Inc.,  
Cincinnati,  OH,  USA) methods.
a) Achromopeptidase extraction
　 P. acnes was washed with Tris-EDTA buﬀer 
(10mM Tris-HCl,  1mM EDTA,  pH8.0,  TE buﬀer) 
and centrifuged at 3,000rpm for 5min.  The precipita-
tion containing P. acnes was suspended in 200µl of 
achromopeptidase solution (250U/ml,  WAKO,  Osaka,  
Japan),  and was incubated at 55℃ for 10min.  
Twenty-ﬁve microliters of Proteinase K (Qiagen,  
Tokyo,  Japan) and 200 microliters of solution buﬀer 
(Buﬀer AL,  Qiagen) were added to the solution,  
which was mixed by vortexing and then incubated at 
70℃ for 30min.  Two hundred microliters of ethanol 
were added to the sample,  which was then mixed by 
vortexing.  The mixture was transferred to a QIAamp 
Spin Column (Qiagen) in a 2-ml collection tube,  and 
the sample was centrifuged at 6,000×g for 1min.  
Five hundred microliters of washing buﬀer 1 (Buﬀer 
AW1,  Qiagen) was added to the column,  and the 
sample was centrifuged at 6,000×g for 1min.  
Furthermore,  washing buﬀer 2 (Buﬀer AW2,  Qiagen) 
was added and centrifuged at 10,000×g for 3min.  A 
total of 200µl of elution buﬀer (Buﬀer AE,  Qiagen) 
was added to the sample,  which was then incubated at 
room temperature for 5min.  After centrifugation of 
the sample at 6,000×g for 1min,  the DNA was 
eluted.
b) BACTOZOL extraction
　 Lysis solution containing Bactozyme (Molecular 
Research Center,  Inc.,  Cincinnati,  OH,  USA),  TE 
buﬀer,  and DNAzol were prepared.  P. acnes was 
washed with TE buﬀer and centrifuged at 3,000rpm 
for 5min.  The precipitation containing P. acnes was 
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suspended in 200µl of lysis solution.  The suspension 
was then mixed by vortexing and incubated at 50℃ 
for 90min.  The methods of DNA extraction and col-
lection were similar to those used in the Achromo-
peptidase approach.
2. Extraction of DNA from mouse organs. DNA 
was extracted from BAL cells,  lungs,  lymph nodes,  
liver,  and spleen using a QIAamp DNA Mini Kit 
(Qiagen).  Lungs,  lymph nodes,  liver,  and spleen were 
homogenized in a blender; BAL cells were used with-
out homogenization.  Then,  180µl of Buﬀer AL and 
2µl of Protease K were added to a microtube contain-
ing homogenized tissue or BAL cells,  and the samples 
were vortexed for 15sec.  After the solution was 
mixed,  the microtubes were incubated at 56℃ until 
the tissues had completely dissolved.  Then,  200µl of 
Buﬀer AL was added to the samples,  which were then 
incubated at 70℃ for 10min.  Two hundred microli-
ters of 100ｵ ethanol were added to the samples,  
which were then vortexed for 15sec.  After the solu-
tion was mixed,  the DNA was collected using a 
QIAamp Spin Column (Qiagen).  DNA concentrations 
were obtained based on the absorbance,  which was 
read at 260nm using a spectrophotometer.
3. Quantitative measurement of P. acnes DNA by 
real-time PCR. PCR was performed using a 
LightCycler (Roche,  Basel,  Switzerland).  Primers 
PA-F (5ʼ-AACCGCTTTCGCCTGTGA-3ʼ),  PA-R 
(5ʼ-ACGCTCAGGGTTAAGCCC-3ʼ),  and TaqMan 
Probe (5 ʼ -FAM -AGCGTTGTCCGGATTT 
ATTGGGCG-TAMRA-3ʼ) were designed to amplify 
the P. acnes 16S rRNA.  P. acnes DNA used as the 
control was suspended in a 10-fold serial dilution of 
100µg/ml.  DNA extracted from the mouse organs was 
prepared in amounts of 100ng/µl.  The PCR was car-
ried out in a mixture containing 1.6µl of 2.5mM 
MgCl2,  0.4µl of 10µM Primer-F,  0.4µl of 10µM 
primer-R,  1.0µl of 2µM TaqMan Probe (Japanese 
Gene Institute,  Sendai,  Japan),  2µl of LC Faststart 
DNA Master Hybridization probe (Roche),  1.0µl of 
sample DNA (100ng/µl),  and distilled water,  to yield 
a 20-µl mixture.  The PCR was performed in a 
LightCycler,  with a ﬁrst step of 10min at 95℃,  50 
cycles of 95℃ for 10 sec,  and 62℃ for 20 sec.  The 
concentration of DNA was expressed in terms of the 
number of bacterial genomes using the conversion fac-
tor 2.5×109 Da per genome [9].
　 Statistical analysis. All results are expressed 
as mean ± SEM.  Analysis of variance (ANOVA) was 
used to determine the level of diﬀerence among 
groups.  Signiﬁcance was deﬁned as a p value of less 
than 0.05.
Results
　 BAL cell ﬁndings. Two milliliters of PBS 
were instilled into the lungs,  and the BAL ﬂuid was 
collected.  The total collected cell counts in groups 1,  
2,  3,  and 4 were 3.7±0.8×104/ml,  6.3±0.7×104/
ml,  6.8±0.6×104/ml,  and 6.1±0.9×104/ml,  respec-
tively.  The total cell count for group 3 was signiﬁ-
cantly higher than that of group 1 (p＜0.05).  Cell 
counts in groups 2 and 4 were increased,  but the dif-
ferences between the cell counts of these groups and 
that of group 1 were not signiﬁcant.  There were no 
signiﬁcant diﬀerences among groups in terms of the 
density of macrophages.  The density of lymphocytes 
in group 3 was signiﬁcantly higher than that of group 
1 (p＜0.01).  The density of BAL lymphocytes in 
groups 2 and 4 was higher than that of the other 2 
groups,  but the diﬀerence from group 1 was not sig-
niﬁcant (Fig.  2).  As regards the lymphocyte subset in 
BAL cells determined by ﬂow-cytometric analysis,  no 
signiﬁcant diﬀerences were observed in the percentage 
of CD3＋ cells among groups,  although the percentage 
of CD4＋ cells in group 3 was signiﬁcantly higher than 
that of group 1 (p＜0.05),  and the percentage of 
CD8＋ cells in group 3 (p＜0.05) was also signiﬁ-
cantly lower than that of group 1 (Fig.  3).  As regards 
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Fig. 2　 Cell composition in the bronchoalveolar lavage (BAL) ﬂuid 
of each group after sensitization and challenge with P. acnes.  Mac,  
macrophages; Lym,  lymphocytes; Nt,  neutrophils.  Values are 
mean±SEM.  ＊p＜0.05,  ＊＊p＜0.01 versus group 1 (control).
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the density of lymphocytes in the BAL ﬂuid,  the 
density of CD3＋ cells in group 3 was signiﬁcantly 
higher than that of group 1,  and the density of CD4＋ 
cells was higher in groups 2,  3,  and 4 than in group 
1,  with a signiﬁcant diﬀerence between groups 3 and 
1 (p＜0.01).  The density of CD8＋ cells in groups 2 
and 3 was signiﬁcantly higher than that of group 1 (p
＜0.01) (Fig.  4).  The CD4＋/CD8＋ ratio in groups 
2 (p＜0.05) and 3 (p＜0.01) were signiﬁcantly higher 
than that of group 1 (Fig.  5).
　 Histological ﬁndings. There were no granu-
lomatous changes seen in the lungs of group 1 mice,  
and no abnormal ﬁndings were observed (Fig.  6A).  
The formation of an epitheloid cell granuloma was seen 
in group 2,  and lymphocytic inﬁltrations into the 
alveolar walls were also noted.  These granulomatous 
lesions appeared to be immature (Fig.  6B).  In group 
3,  epitheloid cell granulomas with giant cells were 
present in the lungs,  and the alveolar walls were 
thickened by macrophage and lymphocyte inﬁltration 
(Fig.  6C).  In group 4,  lymphocyte inﬁltration and an 
accumulation of mononuclear cells on the alveolar 
walls were seen,  and loose granulomas were observed 
in the lungs (Fig.  6D).
　 Angiotensin converting enzyme levels in 
serum. Angiotensin converting enzyme activity in 
untreated mice (group 1) was 250±40IU/l/37℃.  
However,  ACE activity was signiﬁcantly higher in all 
other groups than in group 1 (group 2,  310±25IU/
l/37℃,  p＜0.05; group 3,  301±30IU/l/37℃,  p＜
0.01; and group 4,  330±26IU/l/37℃,  p＜0.01) 
(Fig.  7).
　 Antibody levels in response to P. acnes in the 
serum. The antibody levels generated in response 
to P. acnes in mouse serum,  read 5min after the start 
of the reaction at an optical density (O.D.) of ×1,000,  
were as follows: 60.0±10.0 in group 1,  110.0±4.0 
in group 2,  190.0±90.0 in group 3,  and 100.0±20.0 
in group 4.  The levels of P. acnes antibody were sig-
niﬁcantly elevated in groups 2 (p＜0.05) and 3 (p＜
0.01) compared with that of group 1 (Fig.  8).
　 Quantitative real-time PCR of P. acnes DNA.
After PCR was carried out with primers R and F,  
designed to amplify P. acnes,  electrophoresis was 
performed in 2ｵ agarose gel.  The primers revealed 
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a band in the vicinity of 180bp,  as expected according 
to the study design.  The achromopeptidase and 
BACTZOL methods were compared in terms of their 
relative levels of extraction of P. acnes DNA from the 
tissue.  The DNA concentration extracted using the 
Achromopeptidase approach (0.87±0.07µM,  n＝5) 
was signiﬁcantly higher (p＜0.02) than that extracted 
by the BACTZOL method (0.55±0.07µM,  n＝5).  
Therefore,  DNA was extracted using the Achromo-
peptidase method for the remainder of the experi-
ments.  The genome number of P. acnes DNA was 14.2
±5.2×103 per 500 ng of total DNA from the lungs of 
group 1,  21.1±10.1×103 from group 2,  18.3±6.3
×103 from group 3,  and 19.0±3.8×103 from group 
4.  The genome of P. acnes DNA was detected in the 
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Fig. 6　 Histological ﬁndings of lungs after sensitization and challenge with P. acnes in group 1 (A),  2 (B),  3 (C),  and 4 (D).  
Hematoxylin and eosin (HE)-stained sections from each group are shown.  Scale bar,  50µm.
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Fig. 7　 Angiotensin-converting enzyme (ACE) levels in serum 
after sensitization and challenge with P. acnes.  Values are mean±
SEM.  ＊p＜0.05,  ＊＊p＜0.01 versus group 1 as a control.
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Fig. 8　 Antibody level to P. acnes in serum after sensitization 
and challenge with P. acnes.  Values (Optical Density [O.D.]×
1,000) are mean±SEM.  ＊p＜0.05,  ＊＊p＜0.01 versus group 1 
(control).
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lungs of all groups; however,  there were no signiﬁ-
cant diﬀerences between groups (Fig.  9).  The P. acnes 
DNA genome was detected in the lung tissue from non-
treated mice (group 1).  Thus,  the P. acnes genome 
from each organ in group 1 was investigated.  The P. 
acnes DNA number was 14.9±3.5×103 in the lung,  
9.1±3.1×103 in the BAL cells,  7.0±8.0×103 in the 
lymph nodes,  5.2±1.9×103 in the liver,  and 3.2±
3.7×103 in the spleen (Fig.  10).  The genome number 
of P. acnes was higher in the lungs,  BAL cells,  and 
lymph nodes than in the liver and spleen; moreover,  
the number of genomes in the lungs was signiﬁcantly 
higher than that in the liver (p＜0.05) and in the 
spleen (p＜0.01).
Discussion
　 Although sarcoidosis is thought to result from an 
exposure of genetically susceptible subjects to a spe-
ciﬁc environmental agent(s),  its etiology remains 
unknown.  Sarcoidosis is a systemic disease charac-
terized by the presence of noncaseating epitheloid cell 
granulomas.  It commonly involves the lungs,  eyes,  
lymph nodes,  and skin.  A causative agent appears to 
activate alveolar lymphocytes,  which leads to alveoli-
tis and the development of epitheloid cell granulomas 
[13].  This process then results in an increase in the 
T-lymphocyte concentration and the CD4＋/CD8＋ 
ratio in the BAL ﬂuid,  as well as leads to the release 
of various cytokines [14].  Although many putative 
causative agents have been investigated,  no single 
agent has been identiﬁed [1-3].  P. acnes,  an anaero-
bic gram-positive rod,  is the only bacterium to be 
isolated in cultures from biopsy samples of lymph 
nodes from patients with sarcoidosis [5].  In this 
study,  we experimentally produced a murine pulmo-
nary granuloma model using P. acnes with several 
features that simulate sarcoidosis.
　 Mice were immunized with heat-killed P. acnes 
suspended in FCA,  and then received a boost of heat-
killed P. acnes alone at 2-week intervals.  The forma-
tion of epitheloid cell granulomas occurred after the 
second boost.  Moreover,  tight epitheloid granulomas 
with giant cells were found in the group that had 
received 3 boosts.  We performed a series of exami-
nations to elucidate the pathological conditions in 
granulomatous mice.  Initially,  the BAL cell proﬁles 
in granulomatous mice showed elevated total cell and 
lymphocyte counts.  The CD3＋ and CD4＋ lympho-
cyte count and the CD4＋/CD8＋ ratio were higher 
than those of the controls.  In particular,  there were 
signiﬁcantly higher levels of these factors in group 3,  
which received 3 boosts.  Furthermore,  serum ACE 
activity was signiﬁcantly elevated in the sensitized 
groups.  In addition,  the antibody activities in 
response to P. acnes in the serum were signiﬁcantly 
elevated in groups 2 and 3.  Based on these results,  it 
was determined that P. acnes sensitization could pro-
duce experimental granulomatous inﬂammation in the 
81P. acnes-induced Experimental GranulomaApril 2010
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Fig. 9　 Number P. acnes DNA genomes of from lungs in each 
group,  as determined by quantitative real-time polymer chain reac-
tion.  Values (/500ng DNA) are mean±SEM.
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Fig. 10　 Number of genomes of P. acnes DNA genomes from 
lungs,  bronchoalveolar (BAL) ﬂuid,  lymph nodes (LN),  liver,  and 
spleen of control mice (group 1) was determined by quantitative 
real-time polymer chain reaction.  Values (/500ng DNA) are mean
±SEM.  ＊p＜0.05,  ＊＊p＜0.01 versus lungs.
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lungs of mice.  Furthermore,  this model imitates the 
clinical features of sarcoidosis in humans.
　 Ejiri and co-workers [15] reported that an experi-
mental granuloma model in guinea pigs could be pro-
duced by an intratracheal challenge with P. acnes;  
however,  no detailed analysis (e.g.,  of lymphocyte 
subsets of BAL cells) was performed.  P. acnes has 
been recognized as a potent immunostimulant capable 
of producing granulomatous inﬂammation in the liver 
in experimental animals after intravenous injection 
with heat-killed organisms [16].  Although the mecha-
nisms of hepatic granuloma formation in response to P. 
acnes have been extensively investigated,  little has 
been reported on the pulmonary immune response to 
this anaerobic bacterium [17,  18].  Though sensitiza-
tion and boosters were applied at extrapulmonary sites 
in the present model,  granuloma formation occurred 
in the lungs.  On the basis of our observations,  we 
reasoned that a target antigen for inducing granu-
lomatous inﬂammation might have already been present 
in the lungs.  We thus attempted to detect the P. acnes 
genome in lung tissues using real-time PCR,  and we 
conﬁrmed that the genome of P. acnes was indeed pres-
ent in all groups.  In addition,  the genomes of P. acnes 
DNA were present in the lungs,  BAL cells,  hilar 
lymph nodes,  liver,  and spleen of control mice.  
Furthermore,  granuloma formation was found in 
group 4,  in which sensitization was performed only 
using P. acnes,  i.e.,  without complete Freundʼs adju-
vant.  These granulomas appeared to be caused by pre-
existing P. acnes in normal mice.  McCaskill et al.  
[19] produced pulmonary granulomas in C57BL/6 
mice by intraperitoneal sensitization and intratracheal 
challenge with heat-killed P. acnes.  Although in that 
study,  the routes of sensitization and challenge dif-
fered from those used here,  the pulmonary immune 
response in their series supported our results.  In 
group 4,  mice were only challenged using heat-killed 
P. acnes,  without sensitization by a mixture of CFA 
and P. acnes.  The ﬁndings indicate that pre-existing P. 
acnes in mice,  which had been thought to be germ-free,  
caused the development of pulmonary granulomas.  
Nishiwaki et al.  [20] successfully produced pulmonary 
granulomas via the transfer of P. acnes-primed 
T-lymphocytes to non-sensitized mice.  They proposed 
an indigenous mechanism in the pulmonary immune 
response using P. acnes.  It is already known that P. 
acnes is an indigenous bacterium in the skin,  airway,  
and bowel of humans [21].  P. acnes is also thought to 
be an indigenous bacterium in the lower respiratory 
tract and regional lymph nodes,  via the airway,  and 
also appears in the liver and spleen,  via the bowel,  in 
mice.  In our model,  we examined the lungs,  hilar 
lymph nodes,  liver,  and spleen histologically,  but 
granulomatous formations were seen only in the lungs,  
where the genome number of P. acnes was highest 
among those of all organs examined.  Because tightly-
formed granulomas were found,  with density increas-
ing in proportion to the time of challenge,  and as 
antigen levels were relatively high in areas of granu-
loma formation,  indigenous P. acnes is thought to be 
important for granuloma formation in this murine 
model of sarcoidosis.  However,  it should be noted 
that the pathogenesis of sarcoidosis in human is also 
dependent on genetic factors such as HLA and immu-
nity-related genes [13],  and the etiological mecha-
nisms of this disease remain unclear.
　 The present results suggested that P. acnes sensiti-
zation could cause pulmonary inﬂammation,  including 
granuloma formation,  similar to the clinical features 
of sarcoidosis.  It is therefore reasonable to expect 
that P. acnes plays an important etiological role in the 
pathogenesis of sarcoidosis.  The present mouse model 
may be eventually used to develop new treatments for 
sarcoidosis.
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